Aurinia Pharmaceuticals
AUPH
#5262
Rank
A$1.91 B
Marketcap
$13.41
Share price
-1.87%
Change (1 day)
-3.43%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2024 (TTM): -A$23.1 Million

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are A$0.22 Billion. In 2023 the company made an earning of -A$0.12 Billion, an increase over its 2022 earnings that were of -A$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$23.1 Million-80.67%
2023 -A$0.12 Billion-31.8%
2022 -A$0.18 Billion-39.4%
2021 -A$0.29 Billion61.9%
2020 -A$0.18 Billion-9.73%
2019 -A$0.2 Billion92.65%
2018 -A$0.11 Billion36.39%
2017 -A$75.31 Million106.29%
2016 -A$36.51 Million-15.4%
2015 -A$43.15 Million65.84%
2014 -A$26.02 Million129.82%
2013 -A$11.33 Million-26.6%
2012 -A$15.43 Million
2010 -A$8.74 Million-39.22%
2009 -A$14.37 Million-43.78%
2008 -A$25.56 Million-53.19%
2007 -A$54.61 Million42.97%
2006 -A$38.2 Million-23.03%
2005 -A$49.63 Million36.1%
2004 -A$36.47 Million172.57%
2003 -A$13.38 Million484.61%
2002 -A$2.29 Million
2000 -A$10.87 Million453.81%
1999 -A$1.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$7.95 B-32,918.65%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$8.78 Million-63.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$35.4 Million 46.09%๐Ÿ‡บ๐Ÿ‡ธ USA